These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27399224)

  • 1. Persistent psychotic symptoms after long-term heavy use of mephedrone: A two-case series.
    Barrio P; Gaskell M; Goti J; Vilardell S; Fàbregas JM
    Adicciones; 2016 Jun; 28(3):154-7. PubMed ID: 27399224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychotic disorders related with chronic use of mephedrone. Case report].
    Urban M; Rudecki T; Wróblewski D; Rabe-Jabłońska J
    Psychiatr Pol; 2011; 45(3):431-7. PubMed ID: 22232972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of 2 Populations of Mephedrone Abusers by Hair Testing. Application to 4 Forensic Expertises.
    Kintz P
    Curr Neuropharmacol; 2017; 15(5):658-662. PubMed ID: 27784226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mephedrone, new kid for the chop?
    Winstock AR; Mitcheson LR; Deluca P; Davey Z; Corazza O; Schifano F
    Addiction; 2011 Jan; 106(1):154-61. PubMed ID: 20735367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence and psychosis with 4-methylmethcathinone (mephedrone) use.
    Bajaj N; Mullen D; Wylie S
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.
    Freeman TP; Morgan CJ; Vaughn-Jones J; Hussain N; Karimi K; Curran HV
    Addiction; 2012 Apr; 107(4):792-800. PubMed ID: 22257011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Psychosis, Drug Dependence, and Hepatitis C Related to Slamming Mephedrone.
    Dolengevich-Segal H; Rodríguez-Salgado B; Gómez-Arnau J; Sánchez-Mateos D
    Case Rep Psychiatry; 2016; 2016():8379562. PubMed ID: 27247820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mephedrone: a new synthetic drug].
    Petit A; Karila L; Sananes M; Lejoyeux M
    Presse Med; 2013 Oct; 42(10):1310-6. PubMed ID: 23669315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users.
    Homman L; Seglert J; Morgan MJ
    Psychopharmacology (Berl); 2018 Sep; 235(9):2609-2618. PubMed ID: 29946859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.
    Schifano F; Albanese A; Fergus S; Stair JL; Deluca P; Corazza O; Davey Z; Corkery J; Siemann H; Scherbaum N; Farre' M; Torrens M; Demetrovics Z; Ghodse AH; ;
    Psychopharmacology (Berl); 2011 Apr; 214(3):593-602. PubMed ID: 21072502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity.
    Wood DM; Dargan PI
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):227-33. PubMed ID: 22564711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pharmacology of the Synthetic Cathinone Mephedrone.
    Papaseit E; Moltó J; Muga R; Torrens M; de la Torre R; Farré M
    Curr Top Behav Neurosci; 2017; 32():313-331. PubMed ID: 28012094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mephedrone: Public health risk, mechanisms of action, and behavioral effects.
    Dybdal-Hargreaves NF; Holder ND; Ottoson PE; Sweeney MD; Williams T
    Eur J Pharmacol; 2013 Aug; 714(1-3):32-40. PubMed ID: 23764466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mephedrone use among same-sex attracted young people in Sydney, Australia.
    Lea T; Reynolds R; De Wit J
    Drug Alcohol Rev; 2011 Jul; 30(4):438-40. PubMed ID: 21450044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat.
    Shortall SE; Macerola AE; Swaby RT; Jayson R; Korsah C; Pillidge KE; Wigmore PM; Ebling FJ; Richard Green A; Fone KC; King MV
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1085-95. PubMed ID: 23051939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitutional potential of mephedrone: an analysis of the subjective effects.
    Kapitány-Fövény M; Kertész M; Winstock A; Deluca P; Corazza O; Farkas J; Zacher G; Urbán R; Demetrovics Z
    Hum Psychopharmacol; 2013 Jul; 28(4):308-16. PubMed ID: 23881878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
    Dargan PI; Sedefov R; Gallegos A; Wood DM
    Drug Test Anal; 2011; 3(7-8):454-63. PubMed ID: 21755604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
    Uosukainen H; Tacke U; Winstock AR
    Int J Drug Policy; 2015 Jan; 26(1):78-83. PubMed ID: 25107829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "A costly turn on": patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors.
    Van Hout MC; Bingham T
    Int J Drug Policy; 2012 May; 23(3):188-97. PubMed ID: 22342322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.